United Immunity
@unitedimmunity.co.jp
United Immunity's mission is to proactively and selectively target myeloid cells to deliver an innovative clinical experience to patients with cancer and infectious diseases. To achieve this, we are developing innovative nanoparticle and lipid nanoparticle (LNP) based on Cholesteryl Pullulan to selectively deliver therapeutic agents to macrophages, dendritic cells, as well as other myeloid cells such as tumor-associated macrophages (TAM), Kupffer cells in the liver, adipose tissue macrophages, and microglia. Our technology can be combined with various payloads including small molecules, mRNA, siRNA, DNA, peptides, proteins, and antibody fragments. United Immunity's Pullulan nanoparticle (PNP) and Pullulan LNP (P-LNP) are ideally suited for cancer and infectious disease vaccines, and have the potential for the treatment of fibrosis, inflammation, autoimmune, and metabolic diseases. Our lead program, UI-102, applies our pullulan nanoparticle to precisely deliver a Toll-like receptor (TLR) agonist to M2-like tumor macrophages in order to modulate the tumor microenvironment from “cold (immune-suppressed)” to “hot (immune-activated)”. UI-102 aims to increase the efficacy of checkpoint inhibitors and other immunotherapy agents while significantly reducing safety risks associated with TLR agonism. We are also using our technology to boost the effectiveness of T-cell therapies and generate in vivo CAR-macrophages.
United Immunity's Company Logos
United Immunity's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#F0830E
Tango
240, 131, 14
31, 89, 50
0, 45, 94, 6
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#0B5987
Venice Blue
11, 89, 135
202, 85, 29
92, 34, 0, 47
About United Immunity
United Immunity is a leading biotechnology company that specializes in creating innovative immunotherapies using nanotechnology. With a focus on tackling difficult-to-treat cancers and infectious diseases, United Immunity combines the power of immunity and nanotechnology to revolutionize treatment options. By harnessing the potential of nanotechnology, the company develops cutting-edge therapies that offer new hope for patients.
Their commitment to scientific advancement is evident in their active participation in conferences and scientific meetings, where they present the research achievements of their development products. United Immunity aims to overcome the challenges posed by cancer and infectious diseases by constantly pushing the boundaries of immunotherapy. For any inquiries or questions, they provide a convenient contact form for customers to reach out.
Trust United Immunity to revolutionize the fight against cancer and infectious diseases through the fusion of immunity and nanotechnology
Company type
Privately Held
Year founded
2017
Company size
11-50 employees
